RedHill Biopharma (RDHL) Other Accumulated Expenses (2018 - 2026)
RedHill Biopharma (RDHL) posted Other Accumulated Expenses of $500,000 for the quarter ended Jun 30, 2026, unchanged from $500,000 a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Since the quarter ended Dec 31, 2018, RedHill Biopharma has reported Other Accumulated Expenses for 25 quarters.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of -7.8% (years ended Dec 2020 to Dec 2025).
- In prior years, RedHill Biopharma's Other Accumulated Expenses was $500,000 in the year ended Dec 31, 2024 (-7.4%), $540,000 in the year ended Dec 31, 2023 (-28.0%), $750,000 in the year ended Dec 31, 2022 (unchanged) and $750,000 in the year ended Dec 31, 2021 (unchanged).
- Quarterly Other Accumulated Expenses has run from a low of $500,000 in the quarter ended Dec 31, 2024 to a high of $750,000 in the quarter ended Jun 30, 2023 over five years.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was the quarter ended Sep 30, 2021, with growth of 50.0%; the weakest was the quarter ended Dec 31, 2023, with a decline of 28.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | RedHill Biopharma | 7.38 Mn | 7.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Jun 30, 2024 | 540,000.00 |
| Dec 31, 2023 | 540,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Sep 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 750,000.00 |
| Mar 31, 2022 | 750,000.00 |
| Dec 31, 2021 | 750,000.00 |
| Sep 30, 2021 | 750,000.00 |
| Jun 30, 2021 | 750,000.00 |
| Mar 31, 2021 | 750,000.00 |
| Dec 31, 2020 | 750,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 500,000.00 |
API Access
RedHill Biopharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();